Equities Analysts Offer Predictions for ITOS FY2024 Earnings

1 day ago · Read Equities Analysts Offer Predictions for ITOS FY2024 Earnings at Defense World ... EPS, FY2026 earnings at ($5.26) EPS, FY2027 earnings at ($4.54) EPS and FY2028 …

CouponFollow Extension

$5.26
OFF

Equities Analysts Offer Predictions For ITOS FY2024 Earnings

1 week from now

1 day ago · Read Equities Analysts Offer Predictions for ITOS FY2024 Earnings at Defense World ... EPS, FY2026 earnings at ($5.26) EPS, FY2027 earnings at ($4.54) EPS and FY2028 …

defenseworld.net

$8.23
OFF

Wedbush Forecasts Stronger Earnings For ITeos Therapeutics

1 week from now

1 day ago · Read Our Latest Stock Analysis on ITOS. iTeos Therapeutics Trading Down 2.7 %. Shares of iTeos Therapeutics stock opened at $8.23 on Friday. The business’s fifty day …

etfdailynews.com

$108136000
OFF

Iteos Therapeutics Inc Stock Forecast, Predictions & Price Target

1 week from now

Iteos Therapeutics. 's earnings in 2024 is -$108,136,000.. On average, 3 Wall Street analysts forecast ITOS's earnings for 2024 to be -$133,060,038, with the lowest ITOS earnings forecast …

wallstreetzen.com

$10.11
OFF

Equities Analysts Issue Forecasts For IBM FY2024 Earnings

1 week from now

1 day ago · Zacks Research analyst S. Bose now forecasts that the technology company will post earnings of $10.11 per share for the year, up from their previous forecast of $10.05.

etfdailynews.com

$0.32
OFF

Equities Analysts Offer Predictions For ATOS FY2026 Earnings

1 week from now

2 days ago · HC Wainwright analyst E. Bodnar now anticipates that the company will post earnings per share of ($0.32) for the year, down from their prior forecast of ($0.21). HC …

marketbeat.com

$2.42
OFF

Equities Analysts Offer Predictions For AGO FY2024 Earnings

1 week from now

3 days ago · The financial services provider reported $2.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $1.00. Assured Guaranty had a …

marketbeat.com

FAQs about Equities Analysts Offer Predictions for ITOS FY2024 Earnings Coupon?

Will iTeos Therapeutics' Revenue perform worse next year?

It's pretty clear that iTeos Therapeutics' revenues are expected to perform substantially worse than the wider industry. The most obvious conclusion is that the analysts made no changes to their forecasts for a loss next year. ...

How much does iTeos Therapeutics stock cost?

Shares of iTeos Therapeutics stock opened at $8.23 on Friday. The business’s fifty day moving average price is $10.40 and its 200 day moving average price is $13.99. iTeos Therapeutics has a twelve month low of $7.99 and a twelve month high of $18.75. The stock has a market capitalization of $300.64 million, a P/E ratio of -2.69 and a beta of 1.39. ...

Who owns iTeos Therapeutics?

Candriam S.C.A. acquired a new stake in iTeos Therapeutics during the 2nd quarter valued at approximately $7,558,000. Kennedy Capital Management LLC purchased a new stake in iTeos Therapeutics during the 1st quarter worth approximately $1,988,000. ...

Did analysts change their forecasts for a loss next year?

The most obvious conclusion is that the analysts made no changes to their forecasts for a loss next year. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. ...